Maguy Daures
Biographic Data
| ID | 5458922 |
|---|---|
| NAME | Maguy Daures |
| GIVEN NAMES | Maguy |
| FAMILY NAME | Daures |
| SIGNATURE | DAURES M |
| AFFILIATIONS | Université de Bordeaux |
| ORCID | 0000-0003-2878-4524 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Assessing WHO prioritisation criteria for children 6–59 months treated for moderate wasting in a Muac-based protocol
BACKGROUND: In 2023, the WHO recommended prioritising treatment for moderately wasted children with higher risk characteristics, including mid-upper arm circumference (MUAC) 115-119 mm, weight-for-age z-score (WAZ) <-3, age <24 months or clinical and social vulnerabilities. However, applying multiple criteria is operationally challenging. The OptiMA (Optimising Acute Malnutrition Treatment) protocol treats children with MUAC <125 mm or oedema usi…
Factors associated with non-response and nutritional status of non-responders at 6-month post-discharge
Background: In the treatment of acute malnutrition (AM), non-response is considered a treatment failure for not meeting recovery criteria within a therapeutic window of 12-16 weeks, but this category of children is misunderstood. As current research emphasizes ways to simplify and optimize treatment protocols, non-response emerges as a new issue to enhance program efficiency. Methods: A prospective cohort study was conducted from 2019 to 2020 at …
Treatment outcomes and associated factors for hospitalization of children treated for acute malnutrition under the OptiMA simplified protocol
Introduction Globally, access to treatment for severe and moderate acute malnutrition is very low, in part because different protocols and products are used in separate programs. New approaches, defining acute malnutrition (AM) as mid-upper arm circumference (MUAC) < 125 mm or oedema, are being investigated to compare effectiveness to current programs. Optimizing Malnutrition treatment (OptiMA) is one such strategy that treats AM with one product…
Utilization patterns, outcomes and costs of a simplified acute malnutrition treatment programme in Burkina Faso
Access to treatment for acute malnutrition remains a challenge, in part due to the fragmentation of treatment programmes based on case severity. This paper evaluates utilization patterns, outcomes and associated costs for treating acute malnutrition cases among a cohort of children in Burkina Faso. This study is a secondary analysis of a proof-of-concept trial, called Optimizing treatment for acute Malnutrition (OptiMA), conducted in Burkina Faso…
No prominent works on this page.
Utilization patterns, outcomes and costs of a simplified acute malnutrition treatment programme in Burkina Faso
Access to treatment for acute malnutrition remains a challenge, in part due to the fragmentation of treatment programmes based on case severity. This paper evaluates utilization patterns, outcomes and associated costs for treating acute malnutrition cases among a cohort of children in Burkina Faso. This study is a secondary analysis of a proof-of-concept trial, called Optimizing treatment for acute Malnutrition (OptiMA), conducted in Burkina Faso…
Treatment outcomes and associated factors for hospitalization of children treated for acute malnutrition under the OptiMA simplified protocol
Introduction Globally, access to treatment for severe and moderate acute malnutrition is very low, in part because different protocols and products are used in separate programs. New approaches, defining acute malnutrition (AM) as mid-upper arm circumference (MUAC) < 125 mm or oedema, are being investigated to compare effectiveness to current programs. Optimizing Malnutrition treatment (OptiMA) is one such strategy that treats AM with one product…
Factors associated with non-response and nutritional status of non-responders at 6-month post-discharge
Background: In the treatment of acute malnutrition (AM), non-response is considered a treatment failure for not meeting recovery criteria within a therapeutic window of 12-16 weeks, but this category of children is misunderstood. As current research emphasizes ways to simplify and optimize treatment protocols, non-response emerges as a new issue to enhance program efficiency. Methods: A prospective cohort study was conducted from 2019 to 2020 at …
Assessing WHO prioritisation criteria for children 6–59 months treated for moderate wasting in a Muac-based protocol
BACKGROUND: In 2023, the WHO recommended prioritising treatment for moderately wasted children with higher risk characteristics, including mid-upper arm circumference (MUAC) 115-119 mm, weight-for-age z-score (WAZ) <-3, age <24 months or clinical and social vulnerabilities. However, applying multiple criteria is operationally challenging. The OptiMA (Optimising Acute Malnutrition Treatment) protocol treats children with MUAC <125 mm or oedema usi…
Child Nutrition and Water Access (4 works) · Malnutrition (4 works) · Severe Acute Malnutrition (4 works) · Cohort (3 works) · Cohort study (3 works) · Internal Medicine (3 works) · Logistic regression (3 works) · Medicine (3 works) · Pediatrics (3 works) · Child Nutrition and Feeding Issues (2 works)